Valuation : Ibnsina Pharma

Market Cap 13.08B 255M 220M 208M 189M 354M 24.36B 355M 2.47B 950M 12.39B 957M 936M 39.16B P/E 2026 *
10.7x
P/E 2027 * 7.29x
Enterprise Value 18.9B 368M 317M 300M 272M 511M 35.18B 514M 3.57B 1.37B 17.9B 1.38B 1.35B 56.56B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.19x
Free-Float
70.08%
Yield 2026 *
2.31%
Yield 2027 * 4.47%
1 day+0.23%
1 week-1.29%
Current month+0.46%
1 month-7.29%
3 months+13.46%
6 months+21.65%
Current year+10.75%
1 week 12.9
Extreme 12.9
13.69
1 month 12.75
Extreme 12.75
13.98
Current year 9.63
Extreme 9.63
16.93
1 year 9.63
Extreme 9.63
16.93
3 years 1.78
Extreme 1.78
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 18/12/2000
Chief Executive Officer - 18/12/2000
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 18/12/2000
Director/Board Member - 18/12/2000
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-1.29%+23.74%+512.26% 255M
+0.29%-6.26%-49.51%-19.40% 14.13B
-0.62%-4.79%-21.65%-13.49% 6.33B
+0.50%-3.82%-58.06%-36.15% 6.22B
-0.84%-1.83%-14.13%-22.39% 4.06B
-1.35%-0.05%-17.88%-38.82% 3.17B
-1.39%-5.80%+0.85%-30.67% 3B
-4.23%-7.07%-48.73%-29.85% 2.7B
-0.43%+7.04%+44.03% - 2.76B
-1.19%+0.28%-16.90%-7.41% 2.49B
Average -0.90%-2.22%-15.82%+34.90% 4.51B
Weighted average by Cap. -0.53%-3.56%-30.03%-20.28%

Financials

2026 *2027 *
Net sales 89.87B 1.75B 1.51B 1.43B 1.29B 2.43B 167B 2.44B 16.97B 6.53B 85.12B 6.58B 6.43B 269B 101B 1.97B 1.7B 1.61B 1.46B 2.74B 188B 2.75B 19.1B 7.35B 95.83B 7.41B 7.24B 303B
Net income 1.33B 25.85M 22.27M 21.09M 19.12M 35.86M 2.47B 36.04M 250M 96.32M 1.26B 97.09M 94.96M 3.97B 1.92B 37.5M 32.31M 30.6M 27.73M 52.03M 3.58B 52.29M 363M 140M 1.82B 141M 138M 5.76B
Net Debt 5.82B 113M 97.66M 92.47M 83.82M 157M 10.83B 158M 1.1B 422M 5.51B 426M 416M 17.41B 5.77B 112M 96.9M 91.76M 83.17M 156M 10.74B 157M 1.09B 419M 5.47B 422M 413M 17.27B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
10/09/26 EGP 12.98 +0.23% 2,624,627
09/09/26 EGP 12.95 -1.75% 5,369,418
08/09/26 EGP 13.18 -2.01% 4,130,647
07/09/26 EGP 13.45 +2.05% 13,202,870
06/09/26 EGP 13.18 +0.23% 5,433,542
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.98EGP
Average target price
17.26EGP
Spread / Average Target
+32.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!